Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo
- 15 April 1981
- journal article
- research article
- Published by Elsevier
- Vol. 17 (4) , 411-420
- https://doi.org/10.1016/0014-2964(81)90250-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- IN VITRO GENERATION OF PRIMARY CYTOTOXIC LYMPHOCYTES AGAINST L5178Y LEUKEMIA ANTIGENICALLY ALTERED BY 5-(3,3'-DIMETHYL-l-TRIAZENO)-IMIDAZOLE-4-CARBOXAMIDE IN VIVOTransplantation, 1979
- Tumor-Associated Transplantation Antigen Distinct From H-2k-like Antigens on a BALB/c (H-2d) Fibrosarcoma2JNCI Journal of the National Cancer Institute, 1978
- Secondary Cytotoxic Response In Vitro Against Moloney Lymphoma Cells Antigenically Altered by Drug Treatment In VivoJNCI Journal of the National Cancer Institute, 1978
- Immunopharmacology of 5-(3,3-dIMETHYL-1-triazeno)-imidazole-4-carboxamide (DTIC) (DTIC)Pharmacological Research Communications, 1975
- Cellular immune response to a drug-treated L5178Y lymphoma sublineNature, 1974
- Immune Response to Gross Virus-Induced Lymphoma: Comparison of Two In Vitro Assays of Cell-Mediated ImmunityJNCI Journal of the National Cancer Institute, 1973
- Progressive Loss of H-2 Antigens With Concomitant Increase of Cell-Surface Antigen(s) Determined by Moloney Leukemia Virus in Cultured Murine Lymphomas23JNCI Journal of the National Cancer Institute, 1973
- Specificity of Cellular Immune Reactivity to Virus-induced TumoursNature New Biology, 1972
- IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICEThe Journal of Experimental Medicine, 1967